• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cannabis Stock Movers For July 12, 2024

    7/12/24 4:30:05 PM ET
    $CARA
    $CRBP
    $EAST
    $GENE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $CARA alert in real time by email

    GAINERS:

    • Zelira Therapeutics (OTC:ZLDAF) shares closed up 69.95% at $0.48
    • Global Hemp Group (OTC:GBHPF) shares closed up 40.00% at $0.03
    • CordovaCann (OTC:LVRLF) shares closed up 29.03% at $0.04
    • Elixinol Wellness (OTC:ELLXF) shares closed up 25.00% at $0.00
    • Eastside Distilling (NASDAQ:EAST) shares closed up 23.57% at $1.20
    • Body and Mind (OTC:BMMJ) shares closed up 15.70% at $0.04
    • Pharmadrug (OTC:LMLLF) shares closed up 15.25% at $0.01
    • 1933 Industries (OTC:TGIFF) shares closed up 14.86% at $0.01
    • Maple Leaf Green World (OTC:MGWFF) shares closed up 10.69% at $0.03
    • Corbus Pharmaceuticals (NASDAQ:CRBP) shares closed up 10.42% at $58.92
    • Rocky Mountain High (OTC:RMHB) shares closed up 8.33% at $0.01
    • Village Farms Intl (NASDAQ:VFF) shares closed up 8.18% at $1.07
    • Greenlane Hldgs (NASDAQ:GNLN) shares closed up 7.67% at $0.28
    • Urban-gro (NASDAQ:UGRO) shares closed up 5.48% at $1.50
    • Mexco Energy (AMEX:MXC) shares closed up 5.00% at $11.98
    • MariMed (OTC:MRMD) shares closed up 4.94% at $0.17
    • 22nd Century Group (NASDAQ:XXII) shares closed up 4.42% at $0.86
    • Charlottes Web Holdings (OTC:CWBHF) shares closed up 3.69% at $0.17

    LOSERS:

    • CLS Holdings USA (OTC:CLSH) shares closed down 27.84% at $0.04
    • Genetic Technologies (NASDAQ:GENE) shares closed down 24.32% at $0.80
    • Target Group (OTC:CBDY) shares closed down 12.33% at $0.00
    • Cansortium (OTC:CNTMF) shares closed down 10.87% at $0.10
    • 4Front Ventures (OTC:FFNTF) shares closed down 7.18% at $0.09
    • Global Compliance (OTC:FUAPF) shares closed down 4.70% at $0.01
    • iAnthus Capital Hldgs (OTC:ITHUF) shares closed down 4.17% at $0.02
    • CNBX Pharmaceuticals (OTC:CNBX) shares closed down 4.05% at $0.01
    • Cara Therapeutics (NASDAQ:CARA) shares closed down 3.28% at $0.35

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $CARA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CARA
    $CRBP
    $EAST
    $GENE

    CompanyDatePrice TargetRatingAnalyst
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2025$28.00Buy
    B. Riley Securities
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    2/28/2025Outperform
    William Blair
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    12/2/2024Overweight
    Piper Sandler
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/30/2024$85.00Outperform
    Wedbush
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    7/22/2024$80.00Buy
    H.C. Wainwright
    Corbus Pharmaceuticals Holdings Inc.
    $CRBP
    6/26/2024$85.00Buy
    B. Riley Securities
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$6.00 → $1.00Buy → Hold
    Stifel
    Cara Therapeutics Inc.
    $CARA
    6/13/2024$10.00 → $1.00Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $CARA
    $CRBP
    $EAST
    $GENE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Ip Jonathan Hue-Fay

    3 - Greenlane Holdings, Inc. (0001743745) (Issuer)

    2/4/26 4:55:45 PM ET
    $GNLN
    Durable Goods
    Consumer Discretionary

    Chief Medical Officer Smethurst Dominic sold $26,575 worth of shares (3,285 units at $8.09), decreasing direct ownership by 3% to 95,887 units (SEC Form 4)

    4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)

    2/4/26 4:25:42 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Operating Officer Hodgson Ian sold $19,537 worth of shares (2,415 units at $8.09), decreasing direct ownership by 4% to 51,927 units (SEC Form 4)

    4 - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Issuer)

    2/4/26 4:24:39 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $EAST
    $GENE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for KORSUVA issued to CARA THERAPEUTICS INC

    Submission status for CARA THERAPEUTICS INC's drug KORSUVA (ORIG-1) with active ingredient DIFELIKEFALIN has changed to 'Approval' on 08/23/2021. Application Category: NDA, Application Number: 214916, Application Classification: Type 1 - New Molecular Entity

    8/24/21 12:36:58 PM ET
    $CARA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $EAST
    $GENE
    SEC Filings

    View All

    Mexco Energy Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - MEXCO ENERGY CORP (0000066418) (Filer)

    2/10/26 4:51:41 PM ET
    $MXC
    Oil & Gas Production
    Energy

    SEC Form 10-Q filed by Mexco Energy Corporation

    10-Q - MEXCO ENERGY CORP (0000066418) (Filer)

    2/10/26 4:49:47 PM ET
    $MXC
    Oil & Gas Production
    Energy

    SEC Form 10-Q filed by urban-gro Inc.

    10-Q - urban-gro, Inc. (0001706524) (Filer)

    2/10/26 3:34:03 PM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $CARA
    $CRBP
    $EAST
    $GENE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference

    NORWOOD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP), a clinical-stage company focused on oncology and obesity, today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present a corporate overview and attend investor meetings at the 36th Annual Oppenheimer Healthcare Life Sciences Conference, to be held virtually February 25-25, 2026. 36th Annual Oppenheimer Healthcare Life Sciences Conference Format: Virtual presentation and one-on-one investor meetings Date: February 25, 2026 Presentation Time: 3:20pm Eastern TimeWebcast Link: Click Here About CorbusCorbus Pharmaceuticals Holdings, Inc. is a clinical stage oncolog

    2/12/26 8:00:00 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Mexco Energy Corporation Reports Financial Results for Third Quarter

    MIDLAND, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE:MXC) today reported net income of $615,702, or $0.30 per diluted share, for the nine months ending December 31, 2025. For the third quarter of fiscal 2026, the Company reported net income of $50,245, or $0.02 per diluted share, a decrease of 89% when compared to $469,133, or $0.22 per diluted share, for the prior year quarter. This decrease is primarily due to the decline in oil prices. Operating revenues in the third quarter of fiscal 2026 were $1,383,887. For the nine months ended December 31, 2025, operating revenues were $4,932,806, a decrease of 8% when compared to the first nine months of fiscal 2025. Thi

    2/10/26 5:00:00 PM ET
    $MXC
    Oil & Gas Production
    Energy

    Institutional-Grade Token Architecture Positions Companies at the Center of Digital Finance

    Scalable, compliant infrastructure supports demand for regulated digital assets for growing number of industries  Market News Updates News Commentary NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Digital finance is moving fast, and institutional-grade token architecture is becoming a core piece of the financial system. Large investors and institutions want digital assets that are secure, compliant, and easy to integrate with traditional finance. Tokenized infrastructure built for institutions helps make that possible by supporting regulated transactions, asset-backed tokens, and scalable platforms designed for real-world use, not just experimentation as Active Companies take notice that may include

    2/4/26 8:45:00 AM ET
    $COIN
    $DJT
    $GNLN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    $CARA
    $CRBP
    $EAST
    $GENE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities resumed coverage on Corbus Pharma with a new price target

    B. Riley Securities resumed coverage of Corbus Pharma with a rating of Buy and set a new price target of $28.00

    7/30/25 8:22:15 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    William Blair initiated coverage on Corbus Pharma

    William Blair initiated coverage of Corbus Pharma with a rating of Outperform

    2/28/25 7:22:12 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Piper Sandler initiated coverage on Corbus Pharma

    Piper Sandler initiated coverage of Corbus Pharma with a rating of Overweight

    12/2/24 9:55:40 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $EAST
    $GENE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Executive Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4/A - Village Farms International, Inc. (0001584549) (Issuer)

    6/3/25 9:00:14 PM ET
    $VFF

    Chief Financial Officer Degiglio Michael A bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    6/2/25 6:17:22 AM ET
    $VFF

    Chief Financial Officer Ruffini Stephen C bought $30,150 worth of shares (25,000 units at $1.21), increasing direct ownership by 0.26% to 9,783,127 units (SEC Form 4)

    4 - Village Farms International, Inc. (0001584549) (Issuer)

    6/2/25 6:12:58 AM ET
    $VFF

    $CARA
    $CRBP
    $EAST
    $GENE
    Leadership Updates

    Live Leadership Updates

    View All

    Village Farms International Creates Global Strategy Officer Role and Appoints Brian Stevenson

    Proven tobacco, pharmaceutical, and cannabis executive will lead the Company's enterprise-wide strategic agenda Appointment underscores the Company's commitment to disciplined global expansion and long-term value creation LAKE MARY, Fla., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ:VFF), today announced the appointment of Brian Stevenson to the role of Global Chief Strategy Officer. In this newly created role, Mr. Stevenson will lead the Company's enterprise-wide strategic agenda, including long-term growth strategy, global market assessment, and integration initiatives across regions and business units. Mr. Stevenson wil

    12/17/25 4:30:00 PM ET
    $VFF

    Village Farms Launches Promenade Brand's First Vape in Quebec

    HUNTINGDON, Quebec, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (NASDAQ:VFF), together with its Quebec-based subsidiary Rose LifeScience Inc., today announced the launch of Promenade's first vape product, Matin. This introduction marks a major step forward for Quebec's regulated cannabis market, as Promenade becomes one of the first brands to join the province's new vape category. While meaningful progress has been made in shifting consumers from the illicit to the legal market, the absence of a regulated vape category in Québec until now has limited consumer access to this format. An estimated 21 percent of Québec cannabis consumers previously turned to out-of-pro

    11/24/25 7:00:00 AM ET
    $VFF

    22nd Century Announces First Shipments of Pinnacle VLN® Products to Top 5 C-Store Chain Locations Across 12 States

    Pinnacle VLN® from 22nd Century Gains 2nd Early Adopter to Join Popular Pinnacle Branded Conventional Cigarette Products Already Sold at Top-5 U.S. C-Store Chain MOCKSVILLE, N.C., Aug. 04, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced the first shipments of its new Pinnacle VLN® Gold and Pinnacle VLN® Menthol reduced nicotine content cigarettes into distribution. These initial Pinnacle VLN® shipments will support a sales launch expected on September 1, 2025 at almost 1,000 locations across 12 states for a

    8/4/25 8:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $CARA
    $CRBP
    $EAST
    $GENE
    Financials

    Live finance-specific insights

    View All

    Mexco Energy Corporation Reports Financial Results for Third Quarter

    MIDLAND, TX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE:MXC) today reported net income of $615,702, or $0.30 per diluted share, for the nine months ending December 31, 2025. For the third quarter of fiscal 2026, the Company reported net income of $50,245, or $0.02 per diluted share, a decrease of 89% when compared to $469,133, or $0.22 per diluted share, for the prior year quarter. This decrease is primarily due to the decline in oil prices. Operating revenues in the third quarter of fiscal 2026 were $1,383,887. For the nine months ended December 31, 2025, operating revenues were $4,932,806, a decrease of 8% when compared to the first nine months of fiscal 2025. Thi

    2/10/26 5:00:00 PM ET
    $MXC
    Oil & Gas Production
    Energy

    Institutional-Grade Token Architecture Positions Companies at the Center of Digital Finance

    Scalable, compliant infrastructure supports demand for regulated digital assets for growing number of industries  Market News Updates News Commentary NEW YORK, Feb. 4, 2026 /PRNewswire/ -- Digital finance is moving fast, and institutional-grade token architecture is becoming a core piece of the financial system. Large investors and institutions want digital assets that are secure, compliant, and easy to integrate with traditional finance. Tokenized infrastructure built for institutions helps make that possible by supporting regulated transactions, asset-backed tokens, and scalable platforms designed for real-world use, not just experimentation as Active Companies take notice that may include

    2/4/26 8:45:00 AM ET
    $COIN
    $DJT
    $GNLN
    Finance: Consumer Services
    Finance
    Computer Software: Programming Data Processing
    Technology

    Corbus Pharmaceuticals Reports Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss

    CRB-913 was safe and well-tolerated across all doses studiedDaily neuropsychiatric assessments using CSSRS, PHQ-9, and GAD-7 were negative for all participantsA placebo-adjusted mean weight loss of 2.9% was observed at Day 14 in a dedicated cohort of people with obesity (n=12)A 12-week dose-finding study in people with obesity initiated with completion expected in summer 2026Company to host conference call and live webcast today at 8:00 am ET NORWOOD, Mass., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP), a clinical-stage company focused on oncology and obesity, today announced the completion of the single ascending dose (SAD) and multiple ascending d

    12/11/25 7:00:00 AM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $CARA
    $CRBP
    $EAST
    $GENE
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $CARA
    $CRBP
    $EAST
    $GENE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G/A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 7:48:14 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 6:41:20 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care